2,2-Dichloro-1-(4-fluorophenyl)-2-phenylethanone

2,2-Dichloro-1-(4-fluorophenyl)-2-phenylethanone, with CAS No: 1403667-07-1, is a specialized pharmaceutical intermediate and impurity reference compound associated with the synthetic pathway of atorvastatin and related APIs. Chemical Name: 2,2-dichloro-1-(4-fluorophenyl)-2-phenylethanone; Molecular Formula: C₁₄H₉Cl₂FO; Molecular Weight: 283.13 g/mol. This compound is typically used in impurity identification, process development studies, and analytical method optimization in pharmaceutical laboratories.

It plays a significant role in impurity profiling and reaction monitoring, particularly in ensuring the control of halogenated intermediates and process-related impurities. The compound is utilized in advanced analytical techniques such as HPLC, GC-MS, and LC-MS/MS for precise detection and quantification, supporting regulatory compliance with USP, EP, and ICH impurity guidelines.

Manasa Life Sciences, headquartered in Hyderabad, offers high-quality reference standards and intermediates to pharmaceutical manufacturers and research institutions worldwide. With robust documentation, full traceability, and adherence to Good Documentation Practices (GDP), the company supports impurity characterization, analytical method validation, and regulatory submissions across global markets including Asia, Europe, Africa, the GCC, and the UAE.